Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Arena Pharmaceuticals, Inc.
(NQ:
ARNA
)
7.920
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Arena Pharmaceuticals, Inc.
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
BestOfOTC.com Today's Big Gainers: EPA:PSAT, PWRM, PYBX, RXAC, CXTO, NGD, ARNA
October 01, 2010
from
EmailWire.Com Press Releases
BestOfOTC.com Top volume activities of AMEX: GSS, NGD, RXAC, USOG, AFLB, ARNA
October 01, 2010
from
EmailWire.Com Press Releases
Private Investor Files Lawsuit Against Arena Pharmaceuticals
September 30, 2010
from
GlobeNewswire News Releases
Girard Gibbs LLP Files Class Action Lawsuit Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
September 29, 2010
If You Invested in ARNA Common Stock Between December 8, 2008 and September 16, 2010, You May Be Affected by this Class Action Lawsuit
Read More
from
Business Wire News Releases
Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against Arena Pharmaceuticals, Inc. (Nasdaq: ARNA)
September 28, 2010
from
Business Wire News Releases
Brower Piven Encourages Investors Who Have Losses in Excess of $1,000,000 From Investment in Arena Pharmaceuticals, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action L
September 24, 2010
from
Marketwired News Releases
Izard Nobel LLP Announces Class Action Lawsuit Against Arena Pharmaceuticals, Inc.
September 23, 2010
from
Marketwired News Releases
Investor Notice: The Rosen Law Firm Announces Filing of Securities Class Action Against Arena Pharmaceuticals, Inc. - ARNA
September 22, 2010
from
Business Wire News Releases
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
September 22, 2010
from
Marketwired News Releases
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Arena Pharmaceuticals, Inc.
September 22, 2010
from
Business Wire News Releases
The Law Office of Robbins Umeda LLP Announces an Investigation of Arena Pharmaceuticals, Inc.
September 22, 2010
from
Business Wire News Releases
Sarraf Gentile LLP Files Securities Class Action Against Arena Pharmaceuticals, Inc.
September 21, 2010
from
Marketwired News Releases
Kaplan Fox Files Securities Class Action on Behalf of Purchasers of Arena Pharmaceuticals, Inc. Securities
September 20, 2010
from
Marketwired News Releases
Sarraf Gentile LLP Investigates Arena Pharmaceuticals, Inc.
September 17, 2010
from
GlobeNewswire News Releases
Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
September 16, 2010
from
PR Newswire
Analyst Research on Savient Pharmaceuticals (NASDAQ: SVNT) & Arena Pharmaceuticals (NASDAQ: ARNA) -- Biotech Overview
September 15, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report
Read More
from
Marketwired News Releases
Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
September 13, 2010
from
PR Newswire
Analyst Research on Arena Pharmaceuticals (NASDAQ: ARNA) and Vivus (NASDAQ: VVUS) -- Biotech Overview
September 09, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.
Read More
from
Marketwired News Releases
Analyst Research on Dendreon, Amgen, Arena and Vivus -- Hottest Names in Biotech
August 12, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report
Read More
from
Marketwired News Releases
FDA Confirms September 16th Advisory Committee Meeting to Review Lorcaserin for Obesity and Weight Management
August 06, 2010
from
PR Newswire
Arena Pharmaceuticals to Receive $60 Million from Deerfield Management
August 06, 2010
- Arena to Use $30 Million of Proceeds to Prepay Outstanding Debt -
Read More
from
PR Newswire
Arena Pharmaceuticals Announces Second Quarter 2010 Financial Results and Recent Developments
August 03, 2010
- FDA Completes Successful Pre-Approval Inspection of Arena's Swiss Manufacturing Facility -
Read More
from
PR Newswire
Arena Pharmaceuticals to Present at the BMO Capital Markets 10th Annual Focus on Healthcare Conference
August 03, 2010
from
PR Newswire
Skymark Research Initiates Independent Research Coverage on Arena Pharmaceuticals, Inc.
August 03, 2010
from
GlobeNewswire News Releases
Analyst Research on Ford (NYSE: F), DryShips (NASDAQ: DRYS), Arena Pharmaceuticals (NASDAQ: ARNA), Geron (NASDAQ: GERN) and Many More Available Free at BedfordReport.com
August 02, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.
Read More
from
Marketwired News Releases
Wall Street News Alert: Market Alert: UYMG -- July 29, 2010
July 29, 2010
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding
Read More
from
Marketwired News Releases
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 3
July 27, 2010
from
PR Newswire
Analyst Research on YRC Worldwide (NASDAQ: YRCW), Arena Pharmaceuticals (NASDAQ: ARNA), Onyx Pharmaceuticals (NASDAQ: ONXX), FedEx (NYSE: FDX) and Many More Available Free at BedfordReport.com
July 26, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.
Read More
from
Marketwired News Releases
Liberty Analytics Co. Initiates Independent Research Coverage on Arena Pharmaceuticals, Inc.
July 21, 2010
from
GlobeNewswire News Releases
Analyst Research on Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), VIVUS, Inc. (NASDAQ: VVUS), Apple, Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) and Many More Available Free at Bedfordreport.com
July 16, 2010
Note to Editors: The Following Is an Investment Opinion Being Issued by The Bedford Report.
Read More
from
Marketwired News Releases
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.